A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer

NCT07562490 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

ctDNA
Chemotherapy
Colorectal Cancer

Interventions

DRUG: FOLFOX
DRUG: Folfox plus Bevacizumab

Sponsor

Fudan University